fda compounding glp-1 Novo asks to prevent compounders from making knockoffs US FDA clarifies policies on

There is a meaningful gap between GLP-1 research, fasting research, and combined research

There are currently no medications approved for the treatment of cannabis or stimulant use disorders [34]

Chen et al (75) reported that the Notch signaling pathway contributes to the survival of ovarian stem cells and their resistance to platinum-based chemotherapeutic drugs

doi: 10.1111/j.1469-1809.2012.00705.x 114 ShiM.CaoL.LiuH.ZhouY.ZhaoY.XiaY

Whether paired with sunscreen, moisturizer, or makeup, it helps prep the skin with a dewy, refreshed appearance before facing the day

Lancet Diabetes Endocrinol 6:605617 Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH et al (2019) Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial